XDH and Hepatic fibrosis: Moreover, plasma XO activity, measured by the HPLC fluorescence detection (HPLC-FLD) method, significantly increased on week 1 of CDAHFD (before the establishment of hepatic fibrosis), reaching more than 10-fold on week 6 (Figure 2E).